Tuesday, February 20, 2018 6:52:01 AM
News Link 8K
https://backend.otcmarkets.com/otcapi/company/sec-filings/12562836/content/html
Profile Article
https://jewishwebsite.com/featured/meet-the-top-10-most-influential-israelis-in-international-business-science-and-culture-in-2017/23335/
The Scientist: Dr. Oron Yacoby-Zeevi
Neuroderm Chief Scientist Officer Dr. Oron Yacoby-Zeevi may seem rather unassuming when compared to some of the other game-changers on this list, but there’s a very good reason she joins the other nine candidates.
Israel’s Neuroderm, a clinical-stage pharmaceutical firm developing next-generation treatments for disorders of the central nervous system, was sold to Mitsubishi Tanabe Pharma for $1.1 billion in what is said to be Israel’s largest Pharma exit earlier this year. Yacoby-Zeevi, according to a report in Globes, had a hand in that exit, at least in part, because she is responsible for the company’s technological solution.
NeuroDerm has developed a liquid version of a drug already in existence to treat Parkinson’s Disease. This groundbreaking achievement will certainly improve the lives of patients around the world who suffer from the disease, while also generating profits for the company.
@IsraelCannabis @CNBC @CNBCI @CNN @CNNI @BW @WSJ @FT @nytimes #Marijuana #Marijuanastocks #MedicalMarijuana #MecicalCannabis @CannabisBizNews
Life Comes Down to a Few Short Moments
This Could be One of Them!
Follow me High Profits on Twitter
https://twitter.com/High_Profits
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM